Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Change in Inventory (2018 - 2025)

TELA Bio (TELA) has 8 years of Change in Inventory data on record, last reported at $838000.0 in Q3 2025.

  • For Q3 2025, Change in Inventory rose 3.33% year-over-year to $838000.0; the TTM value through Sep 2025 reached $844000.0, down 46.28%, while the annual FY2024 figure was $3.0 million, 9.35% up from the prior year.
  • Change in Inventory reached $838000.0 in Q3 2025 per TELA's latest filing, up from -$2.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $3.9 million in Q1 2023 and bottomed at -$2.0 million in Q2 2025.
  • Average Change in Inventory over 5 years is $904473.7, with a median of $811000.0 recorded in 2024.
  • Peak YoY movement for Change in Inventory: skyrocketed 3493.18% in 2021, then crashed 1800.87% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $1.5 million in 2021, then tumbled by 131.28% to -$467000.0 in 2022, then plummeted by 68.09% to -$785000.0 in 2023, then surged by 178.47% to $616000.0 in 2024, then skyrocketed by 36.04% to $838000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $838000.0 in Q3 2025, -$2.0 million in Q2 2025, and $1.3 million in Q1 2025.